Lataa...
Targeting the Human Epidermal Growth Factor Receptor Family in Breast Cancer beyond HER2
Currently, the dichotomous definition of human epidermal growth factor receptor 2 (HER2)-positive versus HER2-negative disease undergoing a change through inclusion of the identification of the “HER2-low” category, for which new therapeutic compounds in the form of potent antibody drug conjugates (A...
Tallennettuna:
| Julkaisussa: | Breast Care (Basel) |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
S. Karger GmbH
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768135/ https://ncbi.nlm.nih.gov/pubmed/33447231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510998 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|